Literature DB >> 29560610

Investigating the effect of testosterone by itself and in combination with letrozole on 1,25-dihydroxy vitamin D and FGF23 in male rats.

F Saki1, S R Kasaee1, F Sadeghian1, F Koohpeyma1, G H R Omrani2.   

Abstract

BACKGROUND: Testosterone deficiency might be associated with vitamin D levels in hypogonadal men, but it is not clear whether testosterone can affect vitamin D and fibroblast growth factor-23 (FGF23), either directly or indirectly via aromatization to estradiol. We aimed to investigate the role of testosterone on vitamin D metabolism and serum FGF23 in male rats.
METHODS: A total of 48 male rats were divided into 4 equal groups: sham; O, orchiectomy; O + T, orchiectomized rats treated with testosterone; and O + T + L, orchiectomized rats treated with combination of testosterone and letrozole. We compare the vitamin D metabolism biochemical parameters in these four groups, before and after the study.
RESULTS: We detected a significant reduction in 25-hydroxyvitamin D (25(OH)D), vitamin D binding protein (DBP), FGF23, and 1,25-dihydroxyvitamin D (1,25(OH)2D) serum level in O group compared to sham group (p = 0.004, p = 0.009, p < 0.001 and p < 0.001, respectively), and a significant increase in serum phosphorus, parathyroid hormone (PTH), and alkaline phosphatase (ALP) levels in orchiectomized rats in comparison to sham group (p < 0.001, p = 0.022, and p = 0.006, respectively). However, these changes were corrected by testosterone replacement in O + T and O + T + L groups. In addition, we found that DBP and 1,25(OH)2D serum levels were significantly higher in O + T group in comparison to O + T + L group (p = 0.030 and p = 0.026, respectively).
CONCLUSIONS: Testosterone plays a significant role on regulating 25(OH)D, DBP, FGF23, phosphate (Phos), PTH, and 1,25(OH)2D serum levels in male rats. Also, testosterone has a potent effect on 1,25(OH)2D and DBP by its conversion to estradiol.

Entities:  

Keywords:  1,25(OH)2D; DBP; FGF23; Testosterone

Mesh:

Substances:

Year:  2018        PMID: 29560610     DOI: 10.1007/s40618-018-0875-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  5 in total

1.  p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.

Authors:  F Ewendt; M Föller
Journal:  J Endocrinol Invest       Date:  2019-06-14       Impact factor: 4.256

Review 2.  New concepts in regulation and function of the FGF23.

Authors:  Sanaz Dastghaib; Farhad Koohpeyma; Mesbah Shams; Forough Saki; Aliakbar Alizadeh
Journal:  Clin Exp Med       Date:  2022-06-16       Impact factor: 3.984

3.  Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Oluseye Ogunmoroti; Olatokunbo Osibogun; Di Zhao; Rupal C Mehta; Pamela Ouyang; Pamela L Lutsey; Cassianne Robinson-Cohen; Erin D Michos
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

4.  Vitamin D Deficiency Cause Gender Specific Alterations of Renal Arterial Function in a Rodent Model.

Authors:  Miklós Sipos; Borbála Péterffy; Réka Eszter Sziva; Péter Magyar; Leila Hadjadj; Bálint Bányai; Anita Süli; Eszter Soltész-Katona; Dóra Gerszi; Judit Kiss; Mária Szekeres; György L Nádasy; Eszter Mária Horváth; Szabolcs Várbíró
Journal:  Nutrients       Date:  2021-02-22       Impact factor: 5.717

5.  Effects of Vitamin D Deficiency on Proliferation and Autophagy of Ovarian and Liver Tissues in a Rat Model of Polycystic Ovary Syndrome.

Authors:  Krisztina Lajtai; Csilla Terézia Nagy; Róbert Tarszabó; Rita Benkő; Leila Hadjadj; Réka Eszter Sziva; Dóra Gerszi; Bálint Bányai; Péter Ferdinandy; György László Nádasy; Zoltán Giricz; Eszter Mária Horváth; Szabolcs Várbíró
Journal:  Biomolecules       Date:  2019-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.